Imeds Global Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 26-10-2024
- Paid Up Capital ₹ 20.00 Cr
as on 26-10-2024
- Company Age 3 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1336.64%
(FY 2023)
- Profit -166.37%
(FY 2023)
- Ebitda -129.45%
(FY 2023)
- Net Worth 93.49%
(FY 2023)
- Total Assets 91.96%
(FY 2023)
About Imeds Global
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Imeds Global Private Limited India is Rajasekhara Dondeti as COMPANY SECRETARY. Abburi Vidyasagar, Abburi Sarada, Abburi Sagar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33309AP2021PTC119330
- Company No.
119330
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Imeds Global?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajasekhara Dondeti | Company Secretary | 01-Mar-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abburi Sagar  | Director | 03-Sep-2021 | Current |
| Abburi Vidyasagar | Director | 03-Sep-2021 | Current |
| Abburi Sarada | Director | 10-Oct-2023 | Current |
| Sreenivasa Nimmagadda | Director | 30-Jun-2022 | Current |
| Peddi Rao | Additional Director | 03-Oct-2023 | Current |
Financial Performance and Corporate Structure Insights of Imeds Global.
Imeds Global Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1336.64% increase. The company also saw a substantial fall in profitability, with a 166.37% decrease in profit. The company's net worth Soared by an impressive increase of 93.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imeds Global?
In 2023, Imeds Global had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Avantel LimitedActive 34 years 6 monthsAbburi Vidyasagar, Abburi Sarada and 2 more are mutual person
Wiki Kids Private LimitedActive 20 years 2 monthsAbburi Vidyasagar and Abburi Sagar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Imeds Global?
Imeds Global has a workforce of 24 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imeds Global, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imeds Global's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
